Work

Treatment Efficacy Outcomes Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Survival Analysis of a Phase IB trial

Year: 2023

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.475

Authors: B.A. Morris, T.A. Leal, N. Sethakorn, J. Lang, J. Schehr, S.G. Zhao, Z.S. Morris, D. Buehler, J. Eickhoff, P.M. Harari, A.M. Traynor, T. Campbell, A.M. Baschnagel, M.F. Bassetti

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Emory University, Loyola University Chicago, UW Health University Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387207831

FWCI:

Cites:

Cited by:

Related to: 10